Buradasınız

A REVIEW ON EMERGING TRENDS OF BI-LAYERED TABLETS

Journal Name:

Publication Year:

Abstract (2. Language): 
The purpose of writing this article is to compile the information regarding the bi-layer tablet technology and the various aspects of the bi-layered tablets which are often considered in the successful development of the dosage form. Bi-layer tablet is a new era in the development of controlled release formulation along with various features to provide a way of successful drug delivery system. It is suitable to prepare the tablets in the form of multi layers which are used for the administration of two drugs which are chemically incompatible. Several pharmaceutical companies are currently developing bi-layered tablets, for a variety of reasons such as patent extension, patient compliance, additive effect, reduction of dosage regimen and to achieve sustained release of drugs with minimal side effects. Apart from the advantages it has many so many disadvantages and problem attempt has been made in this review article to introduce the readers to the various aspects of bi-layered tablet technology and various applications in current research.
FULL TEXT (PDF): 
1-20

REFERENCES

References: 

1. Gilbert SB, Neil RA: Tablets, in Leon
Lachman, Herberta Liebermann, Joseph LK,
the theory and practice of industrial
pharmacy, Edition-3. Page no. (a) 293-294,
(b) 330-331, (c) 430-431.
2. William CG and Robert GB: In: Herbert A.
Liebermann, Leon Lachman, Joseph B.
Schwartz pharmaceutical dosage form:
tablets edition-2 Macel Dekkar. Inc.,
Newyork 1989, 1,274.
3. Patel Mehul, Ganesh Nanjan Sockan,
Kavitha and Tamizh Mani: IJPRD. 2:30-38.
4. Divya A, K Kavitha, M Rupesh Kumar and
Dakshayani S: JAPS. 2011: 43-47.
5. Mohamed HG and Furquan NK, IJHR,
2009; 2(1): 23-24.
6. Panchal Hiten Ashok and Tiwari Ajay
kumar: IRJP. 2012:44-49.
7. Shiyani B, Gattani S and Surana: SAAPS
Pharm Sci Tech 2008; 9(3): 818-827.
8. Pranjal kumar singh and Sanjoo kumar:
Journal of drug delivery and therapeutics,
2011; 1(1): 32-356.
9. Kulkarni A and Bhatia M: Development
and evaluation of bi-layer floating tablets of
atenolol and lovastatin for biphasic release
profile. Iran. J. Pharm. Res. 2009; 8: 15–25.
10. Rohan D. Deshpande, DV Gowda, Nawaz
Mahammed and Deepak N. Maramwar:
IJPSR, 2011; 2(10): 2534-2544.
11. ME Aulton, Aulton's Pharmaceutics:
The Design and Manufacture of Medicines,
1974.
12. Shaikh TK, Gadhave MV, Jadhav SL and
Gaikwad DD: IJUPLS. 2012: 450-460
13. The Indian Pharmacopoeia, Vol. 2, 4th
Ed. The Controller of Publication, Govt. of
India, Delhi, 1996: A82-A85
REFERENCES
Review Article ISSN: 2277-8713
Harika IB, IJPRBS, 2012; Volume 1(5):1-20 IJPRBS
Available Online At www.ijprbs.com
14. The United States Pharmacopoeia,
United states Pharmacopoeial convention,
Inc., Rockville, MD, 2000:1944.
15. Singh BN and Kim KH, Journal of Control
Rel. 2000; 63: 235-59.
16. Enose Appavoo Arno, Prithiviraj Anand,
Kesavan Bhaskar, Somasundaram
Ramachandran, Muniyandy Saravanan, and
Radhakrishnan Vinod Chem. Pharm. Bull.
November 2002 :1495-1498.
17. Reddy Sunil, Panakanti Pavan Kumar,
Kandagatla Rajanarayana and Yamsani
Madhusudan Rao: IJPSN. 2010; 3: 851-859.
18. NG Raghavendra Rao, Ashok Yadav and
Upendra Kulkarni: IJCPR. 2010; 2:34-42
19. Howida K. Ibrahim, Ahmed MA,
Mahmoud MG, Drug Discoveries &
Therapeutics. 2010; 4(2):100-108
20. Durga Pattanayak, Subas SD and Ulna
LN: Int j pharm sci tech. 2011; 6(1):44-63.
21. Chirag KP and Priti PP, IJPRD, 2011; 3(7):
16 – 23.

Thank you for copying data from http://www.arastirmax.com